Avecho Biotechnology Limited (AU:AVE) has released an update.
Avecho Biotechnology Limited has announced the cessation of over 83 million options due to the lapse of conditional rights, as conditions for these securities were not met by the expiration date, May 20, 2024. This move could signify important changes in the company’s capital structure and may influence investor decisions.
For further insights into AU:AVE stock, check out TipRanks’ Stock Analysis page.
